← Leaderboards
Bin Zhang
Icahn School Of Medicine At Mount Sinai
$19,809,238
Attributed
$70,034,547
Total exposure
17
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.8M · FY2013–25$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$70,034,547 · 17
By mechanism
U01$31,440,869 · 3
R01$23,647,740 · 7
RF1$11,367,680 · 3
UH3$1,223,120 · 1
UH2$1,177,592 · 1
R56$840,770 · 1
Top collaborators
- Michelle E Ehrlich30 shared
- Vahram Haroutunian26 shared
- Scott Allen Noggle21 shared
- Samuel E Gandy20 shared
- Eric E Schadt20 shared
- Dongming Cai13 shared
- Koichi Iijima11 shared
- Jun Zhu11 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Jeffrey Ohmann Bush$16,044,315
- Stephen R Salton$16,387,402
- Bryn D Webb$1,022,982
- Christian Forst$3,398,952
- Daniel Wacker$3,551,806
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMolecularS DiseaseData SetNetwork ModelsMolecular ProfilingBrainGenesBiologyGeneticPathway InteractionsPathway AnalysisCellsAffectS Disease ModelInduced Pluripotent Stem CellTranscriptomicsValidationMouse ModelProteomicsMolecular ScaleBrain RegionCohortVariant
Grant awards (59)
Examining Unique Markers and Risk Factors for AD/ADRD in Foreign- and Native-born Older Chinese Americans: A Study of Social Determinants of Health, Sleep Patterns, Neuroimaging, and Plasma Biomarkers$4,035,962
R01 · FY2025 · AG
Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans$1,223,120
UH3 · FY2025 · AG
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease$1,189,149
R01 · FY2025 · AG · contact PI
Identification and Characterization of Senescent Cells in Molecular Subtypes of Alzheimer's Disease$806,379
R01 · FY2025 · AG · contact PI
Structural Studies and Drug Discovery to Interrogate the Function of Neuronal SLC4 Transporters$671,775
R01 · FY2025 · NS
Age related loss of immune resilience during response to severe respiratory viral infections$500,424
U01 · FY2025 · AG
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease$1,217,104
R01 · FY2024 · AG · contact PI
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$844,721
R01 · FY2024 · AG · contact PI
Identification and Characterization of Senescent Cells in Molecular Subtypes of Alzheimer's Disease$842,114
R01 · FY2024 · AG · contact PI
Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans$588,100
UH2 · FY2024 · AG
Age related loss of immune resilience during response to severe respiratory viral infections$528,011
U01 · FY2024 · AG
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$846,972
R01 · FY2023 · AG · contact PI
Research Infrastructure for the study of Alzheimer's Disease and Alzheimer's Disease-related dementias in older Asian Americans$589,492
UH2 · FY2023 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$2,272,422
U01 · FY2022 · AG · contact PI
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$847,014
R01 · FY2022 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$842,983
R01 · FY2022 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$419,201
U01 · FY2022 · AG · contact PI
Dissect the interplay between sex and APOE at the single cell level to uncover novel pathways, targets and therapeutics for Alzheimer's disease$3,641,905
RF1 · FY2021 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,848,040
U01 · FY2021 · AG · contact PI
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,211,963
R01 · FY2021 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$984,151
R01 · FY2021 · AG
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$847,487
R01 · FY2021 · AG · contact PI
Identification and characterization of receptors targeting VGF-derived peptides.$169,500
U01 · FY2021 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$3,115,604
U01 · FY2020 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,265,373
U01 · FY2020 · AG · contact PI
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,224,616
R01 · FY2020 · AG · contact PI
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease$845,873
R01 · FY2020 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$842,983
R01 · FY2020 · AG
Identification and characterization of AD risk networks using multi-dimensional "omics" data$756,361
U01 · FY2020 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$164,076
U01 · FY2020 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,691,295
U01 · FY2019 · AG · contact PI
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,248,971
R01 · FY2019 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$843,557
R01 · FY2019 · AG
Characterization of protective roles of ApoE2 against aging and Alzheimer's disease$840,770
R56 · FY2019 · AG
Identification and characterization of AD risk networks using multi-dimensional "omics" data$762,158
U01 · FY2019 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$423,750
U01 · FY2019 · AG · contact PI
Identification and characterization of AD risk networks using multi-dimensional "omics" data$336,850
U01 · FY2019 · AG
Multi-scale network biology approaches to analyze craniofacial expression data$169,500
R03 · FY2019 · DE · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,708,836
U01 · FY2018 · AG · contact PI
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,263,645
R01 · FY2018 · AG · contact PI
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease$867,487
R01 · FY2018 · AG
Identification and characterization of AD risk networks using multi-dimensional "omics" data$793,195
U01 · FY2018 · AG
Multi-scale network biology approaches to analyze craniofacial expression data$167,276
R03 · FY2018 · DE · contact PI
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease$3,514,658
RF1 · FY2017 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$2,699,009
U01 · FY2017 · AG
Integrative Network Modeling of Cognitive Resilience to Alzheimer's Disease$1,322,834
R01 · FY2017 · AG · contact PI
Identification and characterization of AD risk networks using multi-dimensional "omics" data$798,417
U01 · FY2017 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$169,498
U01 · FY2017 · AG
Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis$4,211,117
RF1 · FY2016 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$3,281,179
U01 · FY2016 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,139,520
U01 · FY2016 · AG
Identification and characterization of AD risk networks using multi-dimensional "omics" data$1,011,330
U01 · FY2016 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$168,108
U01 · FY2016 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,702,824
U01 · FY2015 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$111,000
U01 · FY2015 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$96,335
U01 · FY2015 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,734,746
U01 · FY2014 · AG
Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative$114,059
U01 · FY2014 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,659,748
U01 · FY2013 · AG